Morepen Laboratories Share Price
113.68-3.77 (-3.21%)
+127.50% past 1 Year
News
Morepen Laboratories posts higher Q1 revenue at Rs 570 crores year on year
Equity
MOREPENLAB
Morepen Laboratories reports higher first quarter EBITDA and margin
Equity
MOREPENLAB
Morepen Laboratories Q1 consolidated net profit surges sharply year-on-year
Equity
MOREPENLAB
Morepen Laboratories to review and announce Q1 FY27 earnings on August 4
Equity
MOREPENLAB
Morepen Labs starts commercial supply under Rs 825 crore CDMO mandate
Equity
MOREPENLAB
Morepen Labs plans reactor capacity expansion to 600 KL by Q2 end
Equity
MOREPENLAB
Morepen Labs projects 50 percent Q2 FY27 revenue jump from added supplies
Equity
MOREPENLAB
Morepen Labs begins commercial supply under Rs 825 crore CDMO contract
Equity
MOREPENLAB
Morepen Laboratories appoints Sanjay Suri as Managing Director from July 2026
Equity
MOREPENLAB
Morepen Laboratories informs about newspaper publication
Equity
MOREPENLAB
Morepen Laboratories informs about press release
Equity
MOREPENLAB
Morepen Laboratories informs about investor presentation
Equity
MOREPENLAB
Morepen Laboratories reports Profit after tax of 20.12 Crores, in the March 2026 quarter
Equity
MOREPENLAB
Morepen Laboratories Q4 EBITDA and margin decline on year-over-year basis
Equity
MOREPENLAB
Morepen Laboratories Q4 shows softer profit despite modest revenue growth
Equity
MOREPENLAB
USFDA completes inspection at Morepen Laboratories’ Masulakhanna facility with Zero observations
Equity
MOREPENLAB
Morepen Laboratories Completes Fourth Consecutive USFDA Inspection with Zero Observations at Masulkhana Facility.
Equity
MOREPENLAB
Morepen Laboratories Secures Rs 825 Crore Multi-Year CDMO Contract from Global Pharma Major.
Equity
MOREPENLAB
Morepen Laboratories zooms on bagging contract worth Rs 825 crore
Equity
MOREPENLAB
Morepen Laboratories bags contract worth Rs 825 crore
Equity
MOREPENLAB